In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 
Poster Session 6: Lipid management and outcome
Session

Event : ESC Congress 2019

Topic : European Society of Cardiology

  • Session type : Poster Session
  • Date : 03 September 2019
  • Time : 10:30 - 14:30

7 presentations in this session

Adherence to statin therapy drives survival of patients with symptomatic peripheral artery disease

Event : ESC Congress 2019

  • Session : Lipid management and outcome
  • Speaker : JF Dopheide (Bern,CH)

Safety profile of bempedoic acid: pooled analysis of 4 phase 3 clinical trials

Event : ESC Congress 2019

  • Session : Lipid management and outcome
  • Speaker : C Ballantyne (Houston,US)

Joern Fredrik Dopheide speaker

Joern Fredrik Dopheide

Inselspital, Bern (Switzerland)
4
no speaker photo speaker

Ae-Young Her

Kangwon National University School of Medicine, Chuncheon (Korea (Republic of))
7
Christie Ballantyne speaker

Christie Ballantyne

Baylor College of Medicine, Houston (United States of America)
27
no speaker photo speaker

Takao Konishi

Hokkaido University, Sapporo (Japan)
2
Maciej Banach speaker

Maciej Banach

Polish Mother Memorial Hospital Research Institute, Lodz (Poland)
48
Paul Guedeney speaker

Paul Guedeney

Hospital Pitie-Salpetriere, Paris (France)
10
Epameinondas Fountas speaker

Epameinondas Fountas

Onassis Cardiac Surgery Center, Athens (Greece)
2

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are